We use cookies to help us improve your browsing experience and understand how people use our website. Our privacy statement explains how we use cookies, and how to change your cookie settings.
OK
 

Key Financials

 

Consolidated Key Figures

(thousands of €, if not stated otherwise) Third quarter of 2020 Third quarter of 2019 Nine months ended 30 September 2020 Nine months ended 30 September 2019 Full year 2019
INCOME STATEMENT
Revenues 131,816 633,934 333,589 725,719 844,985
Other income 12,201 10,020 35,003 26,744 50,905
R&D expenditure (132,257) (120,680) (398,135) (298,247) (427,320)
S, G&A expenses (44,115) (32,643) (133,612) (61,195) (98,278)
Operating expenses (176,372) (153,323) (531,746) (359,442) (525,597)
Operating profit / loss (-) (32,355) 490,631 (163,154) 393,021 370,292
Net financial results (49,163) (146,226) (83,297) (144,391) (220,233)
Taxes (387) 16,828 (1,096) 16,699 (214)
Net profit / loss (-) (81,905) 361,233 (247,548) 265,329 149,845
 
BALANCE SHEET
Cash and cash equivalents 2,087,797 5,599,787 2,087,797 5,599,787 1,861,616
Current financial investments 3,220,805 - 3,220,805 - 3,919,216
R&D incentives receivables 122,878 99,711 122,878 99,711 115,356
Assets 5,721,086 5,851,752 5,721,086 5,851,752 6,068,609
Shareholders' equity 2,712,082 2,535,281 2,712,082 2,535,281 2,875,658
Deferred income 2,789,183 3,127,777 2,789,183 3,127,777 3,000,646
Other liabilities 219,821 188,695 219,821 188,695 192,305
 
CASH FLOW
Operational cash flow/operational cash burn (-) (*) (202,784) 3,454,585 (433,270) 3,302,041 3,162,804
Cash flow used (-)/generated in operating activities (180,340) 3,470,495 (390,169) 3,328,758 3,208,617
Cash flow generated/used (-) in investing activities (81,084) (14,221) 631,720 (22,881) (3,764,660)
Cash flow generated in financing activities 353 965,072 20,599 970,733 1,335,751
Increase/decrease (-) in cash and cash equivalents (261,073) 4,421,347 262,149 4,276,610 779,708
Transfer to current financial investments - - - - (198,922)
Effect of exchange rate differences on cash and cash equivalents (35,351) 30,514 (35,968) 32,380 (9,966)
Cash and cash equivalents at end of the period 2,087,797 5,599,787 2,087,797 5,599,787 1,861,616
 
Current financial investments at end of the period 3,220,805 - 3,220,805 - 3,919,216
Total current financial investments and cash and cash equivalents at end of the period 5,308,602 5,599,787 5,308,602 5,599,787 5,780,832
 
FINANCIAL RATIOS
Number of shares issued at the end of the period 65,340,842 61,953,831 65,340,842 61,953,831 64,666,802
Basic income / loss (-) per share (in €) (1.25) 6.26 (3.81) 4.77 2.60
Diluted income / loss (-) per share (in €) (1.25) 6.03 (3.81) 4.59 2.49
Share price at the end of the period (in €) 121.20 139.80 121.20 139.80 186.50
Total group employees at the end of the period (number) 1,407 918 1,407 918 1,003

(*) We refer to the note on the cash position of our condensed consolidated interim financial statements for an explanation and reconciliation of this alternative performance measure.

Employees per site as of 30 September 2020 (total: 1,407 employees)

Employees September 2020